Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
As of April 2026, tirzepatide is FDA-approved only as a weekly injection (Mounjaro for type 2 diabetes, Zepbound for weight management)
As research continues to evolve in this area, a better understanding of potential mechanisms and risk factors will provide a more comprehensive picture of this association
1-Year Results: Long-term success with stable weight maintenance and healthier lifestyle habits
Communicate with PlexusDx about schedule changes before you make them
Pregnant or nursing mothers or Individuals with a known medical condition should consult a physician before using this or any dietary
Understanding these potential causes and management strategies can help patients optimize their treatment experience while maintaining therapeutic benefits
